Search research articles
Contact Us
Filters
Showing results (121-130 of 149) with videos related to
Page
of 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka, Pakawat Chongsathidkiet, Kristen Rhodin, et al.
Neurosurgery
|
July 28, 2020
Impact of Intraoperative Magnetic Resonance Imaging and Other Factors on Surgical Outcomes for Newly Diagnosed Grade II Astrocytomas and Oligodendrogliomas: A Multicenter Study
Alexander T Yahanda, Bhuvic Patel, Amar S Shah, et al.
World Neurosurgery
|
January 6, 2020
A Multi-Institutional Analysis of Factors Influencing Surgical Outcomes for Patients with Newly Diagnosed Grade I Gliomas
Alexander T Yahanda, Bhuvic Patel, Garnette Sutherland, et al.
Cancer Discovery
|
October 6, 2021
Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
Maximilian O Schaettler, Megan M Richters, Anthony Z Wang, et al.
Cancer Immunology Research
|
November 21, 2022
The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain
Jay A Bowman-Kirigin, Rupen Desai, Brian T Saunders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2022
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Lakshmi Nayak, Nathan Standifer, Jorg Dietrich, et al.
Neuro-Oncology Advances
|
February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
Andrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.
Neurosurgery
|
April 16, 2021
Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum Investigators
Edjah K Nduom, Melanie Hayden Gephart, Milan G Chheda, et al.
Cancer Discovery
|
February 28, 2024
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population
Anthony Z Wang, Bryce L Mashimo, Maximilian O Schaettler, et al.
Nature Communications
|
March 23, 2023
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer
Kelsy C Cotto, Yang-Yang Feng, Avinash Ramu, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 149) with videos related to
Sort By:
Page
of 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka, Pakawat Chongsathidkiet, Kristen Rhodin, et al.
Neurosurgery
|
July 28, 2020
Impact of Intraoperative Magnetic Resonance Imaging and Other Factors on Surgical Outcomes for Newly Diagnosed Grade II Astrocytomas and Oligodendrogliomas: A Multicenter Study
Alexander T Yahanda, Bhuvic Patel, Amar S Shah, et al.
World Neurosurgery
|
January 6, 2020
A Multi-Institutional Analysis of Factors Influencing Surgical Outcomes for Patients with Newly Diagnosed Grade I Gliomas
Alexander T Yahanda, Bhuvic Patel, Garnette Sutherland, et al.
Cancer Discovery
|
October 6, 2021
Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
Maximilian O Schaettler, Megan M Richters, Anthony Z Wang, et al.
Cancer Immunology Research
|
November 21, 2022
The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain
Jay A Bowman-Kirigin, Rupen Desai, Brian T Saunders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2022
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Lakshmi Nayak, Nathan Standifer, Jorg Dietrich, et al.
Neuro-Oncology Advances
|
February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
Andrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.
Neurosurgery
|
April 16, 2021
Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum Investigators
Edjah K Nduom, Melanie Hayden Gephart, Milan G Chheda, et al.
Cancer Discovery
|
February 28, 2024
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population
Anthony Z Wang, Bryce L Mashimo, Maximilian O Schaettler, et al.
Nature Communications
|
March 23, 2023
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer
Kelsy C Cotto, Yang-Yang Feng, Avinash Ramu, et al.
Page
of 15